Cialis (Tadalafil) and Medicare Advantage Coverage

Does Medicare Advantage Cover Cialis or Tadalafil?

Medicare Advantage (Part C) plans that include prescription drug coverage (MA-PD plans) handle erectile dysfunction medications differently than standard Medicare Part D. Brand-name Cialis lost patent exclusivity in 2018, and since then, most plans have removed it from formularies entirely or placed it on the highest cost-sharing tier.

Generic tadalafil, however, has gained formulary placement across the majority of MA-PD plans. According to the Centers for Medicare & Medicaid Services formulary database, approximately 68% of Medicare Advantage plans with Part D benefits included generic tadalafil on their 2026 formularies. The placement varies: some plans list it at Tier 2 (preferred generic, $10, $25 copay), while others assign it to Tier 3 (non-preferred generic or preferred brand, $30, $60 copay).

A critical detail: Medicare Part D itself has no statutory exclusion for erectile dysfunction drugs. The Medicare Modernization Act of 2003 originally excluded ED medications, but the Inflation Reduction Act's restructuring of Part D benefits and subsequent CMS guidance have allowed plans to include these agents at their discretion. Plans are not required to cover them. They choose to based on competitive positioning and member demand.

How Medicare Advantage Plans Tier Tadalafil

Your actual cost depends on which tier your specific plan assigns to tadalafil and whether quantity limits or step therapy requirements apply.

Plans with the lowest member costs typically place tadalafil 5 mg daily-use tablets at Tier 2, with copays between $10 and $20 for a 30-day supply. The 10 mg and 20 mg as-needed formulations often sit at Tier 3 due to higher per-unit costs and the potential for quantity limit variability.

Prior authorization requirements affect roughly 40% of plans that cover tadalafil. The PA criteria usually require documentation of an erectile dysfunction diagnosis, a trial of at least one PDE5 inhibitor (often sildenafil, given its lower cost), and confirmation that the patient has no contraindicated nitrate use. The American Urological Association guidelines recommend PDE5 inhibitors as first-line therapy for ED, which supports medical necessity documentation [1].

Quantity limits represent the most common utilization management tool. Most plans allow 6 tablets per 30 days for the 10 mg or 20 mg as-needed doses. Daily-use tadalafil 5 mg is typically covered at 30 tablets per month without quantity restrictions beyond the standard days' supply.

What Tadalafil Costs Under Medicare Advantage in 2026

The Inflation Reduction Act capped annual out-of-pocket prescription drug spending at $2,000 for Medicare Part D beneficiaries starting in 2025. This cap applies to MA-PD plans as well, meaning that even if tadalafil sits on a higher tier, your total annual drug spending has a hard ceiling [2].

Here's what real-world costs look like across plan types:

For Tier 2 placement (preferred generic): expect $10, $25 per month for tadalafil 5 mg daily or 6 tablets of 20 mg. Plans from UnitedHealthcare (AARP Medicare Advantage), Humana Gold Plus, and several Blue Cross Blue Shield MA-PD products fall into this category in many regions.

For Tier 3 placement (non-preferred): expect $30, $60 per month. Plans that place tadalafil here often cover sildenafil at Tier 2, using step therapy to steer members toward the lower-cost alternative first.

For plans that exclude tadalafil entirely: you'll pay full cash price unless you use manufacturer or pharmacy discount programs. The average retail cash price for 30 tablets of generic tadalafil 5 mg is $45, $90 depending on pharmacy, according to GoodRx pricing data as of May 2026.

How to Check Your Specific Plan's Coverage

The fastest verification method: call the number on the back of your Medicare Advantage card and ask the pharmacy benefits department three questions. Does your formulary include tadalafil? What tier? Are there prior authorization or quantity limit requirements?

You can also check online through Medicare Plan Finder by entering your zip code, selecting your plan, and searching the formulary for "tadalafil." This tool shows tier placement, restrictions, and estimated copays at network pharmacies in your area.

If your plan denies coverage, you have the right to request a formulary exception. Your prescribing clinician submits a letter of medical necessity explaining why tadalafil is required (for example, if sildenafil caused intolerable side effects or if the 36-hour duration of tadalafil is medically appropriate for the patient's circumstances). The CMS Medicare Appeals Process requires plans to respond to standard exception requests within 72 hours [3].

Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and lead author of the AUA ED guidelines, has stated: "PDE5 inhibitors remain the cornerstone of ED treatment, and access barriers through formulary restrictions do not reflect the clinical evidence supporting their use as first-line therapy" [4].

Strategies to Reduce Your Tadalafil Cost on Medicare

Several approaches can lower what you pay, even within the constraints of Medicare Advantage coverage.

Switch to daily-use 5 mg dosing. Plans that restrict as-needed 20 mg tablets to 6 per month often cover daily-use 5 mg at 30 tablets per month without quantity limits. The per-tablet cost is lower, and daily dosing provides continuous drug levels. A 2007 study in the Journal of Urology (N=268) demonstrated that daily tadalafil 5 mg produced consistent erectile function improvement with an IIEF-EF domain score increase of 6.1 points versus 1.2 for placebo over 24 weeks [5].

Use your plan's preferred pharmacy. Medicare Advantage plans negotiate lower rates with preferred pharmacy networks. Filling at a preferred pharmacy can reduce your copay by $5, $15 per fill compared to a non-preferred in-network pharmacy.

Apply for Extra Help (Low-Income Subsidy). If your income is below 150% of the federal poverty level, the Medicare Extra Help program can reduce copays to $4.50 for generic drugs in 2026 [6].

Consider 90-day mail-order fills. Many MA-PD plans offer 90-day supplies at 2, 2.5x the 30-day copay, effectively giving you a 15 to 25% discount for using mail-order pharmacy.

Tablet splitting (with clinician approval). For as-needed use, a prescriber can write for tadalafil 20 mg tablets and instruct the patient to split them into 10 mg doses. This effectively doubles the supply. The FDA-approved labeling notes that tadalafil tablets are scored and can be divided [7].

Brand Cialis vs. Generic Tadalafil: Coverage Differences

Brand-name Cialis (manufactured by Eli Lilly) is effectively unavailable through Medicare Advantage formularies in 2026. Lilly discontinued active promotion of the brand product after generic entry, and plans have universally favored the generic. If a physician writes "brand medically necessary" on a prescription, the plan may cover it through an exception process, but the cost-sharing will reflect Tier 4 or Tier 5 (specialty/non-preferred brand) pricing of $100+ per month.

Generic tadalafil manufacturers include Teva, Aurobindo, Cipla, Dr. Reddy's, and numerous others. The FDA requires bioequivalence testing confirming that generics deliver the same active ingredient at the same rate and extent as the brand [8]. No clinically meaningful differences in efficacy or safety exist between brand Cialis and FDA-approved generic tadalafil.

Tadalafil for BPH: A Different Coverage Pathway

Tadalafil 5 mg daily carries an FDA-approved indication for benign prostatic hyperplasia (BPH) symptoms, either alone or in combination with ED [9]. This matters for Medicare coverage because plans that exclude tadalafil for ED may still cover it when prescribed for BPH.

The LUTS/BPH indication provides a legitimate clinical rationale that can bypass ED-specific exclusions. A clinician documenting lower urinary tract symptoms (frequency, urgency, weak stream, nocturia) alongside ED can often secure formulary coverage under the BPH indication. The CUA-FDA-approved prescribing information includes data from a 12-week study (N=1,058) showing tadalafil 5 mg improved International Prostate Symptom Score by 4.8 points versus 2.2 for placebo [10].

This is not gaming the system. It's appropriate clinical coding when a patient genuinely has both conditions, which is common. A 2013 BJU International analysis found that 72% of men over 50 with ED also reported moderate-to-severe LUTS [11].

Alternatives If Your Plan Won't Cover Tadalafil

When formulary access fails, other options exist.

Sildenafil (generic Viagra): Nearly all Medicare Advantage plans cover sildenafil at Tier 1 or Tier 2, with copays as low as $3, $10 per month. The JAMA Network meta-analysis of PDE5 inhibitors found comparable overall efficacy across the class, though tadalafil's 36-hour half-life offers a distinct advantage for spontaneity [12].

Compounded tadalafil: Telehealth platforms offer compounded tadalafil at $30, $50 per month without insurance. These products are prepared by 503B outsourcing facilities registered with the FDA. They are not covered by Medicare but may cost less than insurance copays for some patients.

Patient assistance programs: Eli Lilly no longer offers a manufacturer coupon for brand Cialis (since generic availability), but some pharmacy benefit managers have negotiated discount programs for generic tadalafil. NeedyMeds and RxAssist maintain databases of available programs at needymeds.org.

Switching Medicare Advantage plans: During the Annual Enrollment Period (October 15, December 7) or the Medicare Advantage Open Enrollment Period (January 1, March 31), you can switch to a plan that covers tadalafil at a lower tier. Use Medicare Plan Finder to compare formularies specifically for this drug before switching.

The 2025 to 2026 Part D Redesign and ED Medications

The Inflation Reduction Act fundamentally restructured Medicare Part D cost-sharing in 2025, with implications extending into 2026 [13]. Key changes affecting tadalafil access:

The $2,000 annual out-of-pocket cap means that even high-tier tadalafil costs cannot push total drug spending above this ceiling. For patients taking multiple medications, this cap provides a safety net that didn't exist before 2025.

The elimination of the coverage gap ("donut hole") for brand drugs and reduction of generic coinsurance in the gap phase means that patients who previously faced 25% coinsurance on tadalafil in the gap now pay a maximum of 25% for generics through all phases until reaching the cap.

Manufacturer discount obligations under the new structure apply to brand drugs in the coverage gap, but since most patients use generic tadalafil, the more relevant change is the overall cap limiting annual exposure.

Dr. Stacie Dusetzina, Professor of Health Policy at Vanderbilt and researcher on Part D redesign, noted in a Health Affairs analysis: "The $2,000 cap is most protective for patients with multiple chronic conditions whose cumulative spending previously exceeded $7,000 annually before reaching catastrophic coverage" [14].

Comparing Medicare Advantage to Original Medicare for Tadalafil

Original Medicare (Parts A and B) does not cover outpatient prescription drugs at all. You need a standalone Part D plan for drug coverage. Medicare Advantage bundles Part D into the plan, which simplifies administration but limits pharmacy choice.

The trade-off: standalone Part D plans sometimes offer more generous ED drug coverage than MA-PD formularies because they compete solely on drug benefits. However, the premium for a standalone Part D plan plus Medigap supplemental coverage typically exceeds the all-in-one Medicare Advantage premium.

For patients whose primary concern is tadalafil access and cost, comparing specific formularies across plan types during enrollment periods yields better results than making assumptions about which Medicare pathway is "better."